← All medicines

Cancer medicines

Teniposide injection

Independent educational summary · Sources checked November 20, 2026

An intravenous chemotherapy used in selected combination regimens for resistant childhood acute lymphoblastic leukemia.

Profile scope: Teniposide injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Nausea, vomiting, mouth sores, diarrhea and hair loss may occur.

Serious risks and warning signs

Severe blood-cell suppression can cause life-threatening infection or bleeding. Serious allergy can develop during or after infusion. Other cancer, nerve and heart-rhythm risks also require attention. Fever, unexplained bruising, breathing difficulty or fainting needs urgent assessment.

A question for your healthcare team

What blood-count follow-up and infusion-reaction precautions are required, and how long will late effects be monitored?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.